Global Pharmaceutical Excipient Albumin market size is predicted to grow from US$ 882 million in 2025 to US$ 1424 million in 2031; it is expected to grow at a CAGR of 8.3% from 2025 to 2031. Get Access Now!

Global Pharmaceutical Excipient Albumin Market Growth Status and Outlook 2025-2031

The global Pharmaceutical Excipient Albumin market size is predicted to grow from US$ 882 million in 2025 to US$ 1424 million in 2031; it is expected to grow at a CAGR of 8.3% from 2025 to 2031. Albumin is a water-soluble globular protein produced in the liver. It accounts for 50% of blood plasma proteins. These play a vital role in regulating blood volume and act as transporters for molecules such as few hormones, bile salts, and ions. Albumin is commonly used as blood volumizer in rare diseases, burns, shocks, liver conditions, and other blood loss trauma and surgeries The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs. Infinity Market Research newest research report, the Pharmaceutical Excipient Albumin Industry Forecast looks at past sales and reviews total world Pharmaceutical Excipient Albumin sales in 2024, providing a comprehensive analysis by region and market sector of projected Pharmaceutical Excipient Albumin sales for 2025 through 2031. With Pharmaceutical Excipient Albumin sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pharmaceutical Excipient Albumin industry. This Insight Report provides a comprehensive analysis of the global Pharmaceutical Excipient Albumin landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Pharmaceutical Excipient Albumin portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms unique position in an accelerating global Pharmaceutical Excipient Albumin market. This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pharmaceutical Excipient Albumin and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pharmaceutical Excipient Albumin. This report presents a comprehensive overview, market shares, and growth opportunities of Pharmaceutical Excipient Albumin market by product type, application, key manufacturers and key regions and countries. Segmentation by Type: &nbsp;&nbsp;&nbsp; Human Serum Albumin &nbsp;&nbsp;&nbsp; Recombinant Albumin Segmentation by Application: &nbsp;&nbsp;&nbsp; Cell Culture Media &nbsp;&nbsp;&nbsp; Medical Supplements This report also splits the market by region: &nbsp;&nbsp;&nbsp; Americas &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; United States &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Canada &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mexico &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Brazil &nbsp;&nbsp;&nbsp; APAC &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; China &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Japan &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Korea &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Southeast Asia &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; India &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Australia &nbsp;&nbsp;&nbsp; Europe &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Germany &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; France &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; UK &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Italy &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Russia &nbsp;&nbsp;&nbsp; Middle East & Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Egypt &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; South Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Israel &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Turkey &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; GCC Countries The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the companys coverage, product portfolio, its market penetration. &nbsp;&nbsp;&nbsp; CSL &nbsp;&nbsp;&nbsp; Grifols &nbsp;&nbsp;&nbsp; Takeda &nbsp;&nbsp;&nbsp; Octapharma &nbsp;&nbsp;&nbsp; Hualan Bio &nbsp;&nbsp;&nbsp; CBPO &nbsp;&nbsp;&nbsp; Shanghai RAAS &nbsp;&nbsp;&nbsp; Kedrion &nbsp;&nbsp;&nbsp; LFB Group &nbsp;&nbsp;&nbsp; Albumedix &nbsp;&nbsp;&nbsp; Biotest &nbsp;&nbsp;&nbsp; Merck &nbsp;&nbsp;&nbsp; Ventria (InVitria) &nbsp;&nbsp;&nbsp; HiMedia Key Questions Addressed in this Report What is the 10-year outlook for the global Pharmaceutical Excipient Albumin market? What factors are driving Pharmaceutical Excipient Albumin market growth, globally and by region? Which technologies are poised for the fastest growth by market and region? How do Pharmaceutical Excipient Albumin market opportunities vary by end market size? How does Pharmaceutical Excipient Albumin break out by Type, by Application?

1 Scope of the Report &nbsp;1.1 Market Introduction &nbsp;1.2 Years Considered &nbsp;1.3 Research Objectives &nbsp;1.4 Market Research Methodology &nbsp;1.5 Research Process and Data Source &nbsp;1.6 Economic Indicators &nbsp;1.7 Currency Considered &nbsp;1.8 Market Estimation Caveats 2 Executive Summary &nbsp;2.1 World Market Overview &nbsp;2.1.1 Global Pharmaceutical Excipient Albumin Annual Sales 2020-2031 &nbsp;2.1.2 World Current & Future Analysis for Pharmaceutical Excipient Albumin by Geographic Region, 2020, 2024 & 2031 &nbsp;2.1.3 World Current & Future Analysis for Pharmaceutical Excipient Albumin by Country/Region, 2020, 2024 & 2031 &nbsp;2.2 Pharmaceutical Excipient Albumin Segment by Type &nbsp;2.2.1 Human Serum Albumin &nbsp;2.2.2 Recombinant Albumin &nbsp;2.3 Pharmaceutical Excipient Albumin Sales by Type &nbsp;2.3.1 Global Pharmaceutical Excipient Albumin Sales Market Share by Type (2020-2025) &nbsp;2.3.2 Global Pharmaceutical Excipient Albumin Revenue and Market Share by Type (2020-2025) &nbsp;2.3.3 Global Pharmaceutical Excipient Albumin Sale Price by Type (2020-2025) &nbsp;2.4 Pharmaceutical Excipient Albumin Segment by Application &nbsp;2.4.1 Cell Culture Media &nbsp;2.4.2 Medical Supplements &nbsp;2.5 Pharmaceutical Excipient Albumin Sales by Application &nbsp;2.5.1 Global Pharmaceutical Excipient Albumin Sale Market Share by Application (2020-2025) &nbsp;2.5.2 Global Pharmaceutical Excipient Albumin Revenue and Market Share by Application (2020-2025) &nbsp;2.5.3 Global Pharmaceutical Excipient Albumin Sale Price by Application (2020-2025) 3 Global by Company &nbsp;3.1 Global Pharmaceutical Excipient Albumin Breakdown Data by Company &nbsp;3.1.1 Global Pharmaceutical Excipient Albumin Annual Sales by Company (2020-2025) &nbsp;3.1.2 Global Pharmaceutical Excipient Albumin Sales Market Share by Company (2020-2025) &nbsp;3.2 Global Pharmaceutical Excipient Albumin Annual Revenue by Company (2020-2025) &nbsp;3.2.1 Global Pharmaceutical Excipient Albumin Revenue by Company (2020-2025) &nbsp;3.2.2 Global Pharmaceutical Excipient Albumin Revenue Market Share by Company (2020-2025) &nbsp;3.3 Global Pharmaceutical Excipient Albumin Sale Price by Company &nbsp;3.4 Key Manufacturers Pharmaceutical Excipient Albumin Producing Area Distribution, Sales Area, Product Type &nbsp;3.4.1 Key Manufacturers Pharmaceutical Excipient Albumin Product Location Distribution &nbsp;3.4.2 Players Pharmaceutical Excipient Albumin Products Offered &nbsp;3.5 Market Concentration Rate Analysis &nbsp;3.5.1 Competition Landscape Analysis &nbsp;3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025) &nbsp;3.6 New Products and Potential Entrants &nbsp;3.7 Market M&A Activity & Strategy 4 World Historic Review for Pharmaceutical Excipient Albumin by Geographic Region &nbsp;4.1 World Historic Pharmaceutical Excipient Albumin Market Size by Geographic Region (2020-2025) &nbsp;4.1.1 Global Pharmaceutical Excipient Albumin Annual Sales by Geographic Region (2020-2025) &nbsp;4.1.2 Global Pharmaceutical Excipient Albumin Annual Revenue by Geographic Region (2020-2025) &nbsp;4.2 World Historic Pharmaceutical Excipient Albumin Market Size by Country/Region (2020-2025) &nbsp;4.2.1 Global Pharmaceutical Excipient Albumin Annual Sales by Country/Region (2020-2025) &nbsp;4.2.2 Global Pharmaceutical Excipient Albumin Annual Revenue by Country/Region (2020-2025) &nbsp;4.3 Americas Pharmaceutical Excipient Albumin Sales Growth &nbsp;4.4 APAC Pharmaceutical Excipient Albumin Sales Growth &nbsp;4.5 Europe Pharmaceutical Excipient Albumin Sales Growth &nbsp;4.6 Middle East & Africa Pharmaceutical Excipient Albumin Sales Growth 5 Americas &nbsp;5.1 Americas Pharmaceutical Excipient Albumin Sales by Country &nbsp;5.1.1 Americas Pharmaceutical Excipient Albumin Sales by Country (2020-2025) &nbsp;5.1.2 Americas Pharmaceutical Excipient Albumin Revenue by Country (2020-2025) &nbsp;5.2 Americas Pharmaceutical Excipient Albumin Sales by Type (2020-2025) &nbsp;5.3 Americas Pharmaceutical Excipient Albumin Sales by Application (2020-2025) &nbsp;5.4 United States &nbsp;5.5 Canada &nbsp;5.6 Mexico &nbsp;5.7 Brazil 6 APAC &nbsp;6.1 APAC Pharmaceutical Excipient Albumin Sales by Region &nbsp;6.1.1 APAC Pharmaceutical Excipient Albumin Sales by Region (2020-2025) &nbsp;6.1.2 APAC Pharmaceutical Excipient Albumin Revenue by Region (2020-2025) &nbsp;6.2 APAC Pharmaceutical Excipient Albumin Sales by Type (2020-2025) &nbsp;6.3 APAC Pharmaceutical Excipient Albumin Sales by Application (2020-2025) &nbsp;6.4 China &nbsp;6.5 Japan &nbsp;6.6 South Korea &nbsp;6.7 Southeast Asia &nbsp;6.8 India &nbsp;6.9 Australia &nbsp;6.10 China Taiwan 7 Europe &nbsp;7.1 Europe Pharmaceutical Excipient Albumin by Country &nbsp;7.1.1 Europe Pharmaceutical Excipient Albumin Sales by Country (2020-2025) &nbsp;7.1.2 Europe Pharmaceutical Excipient Albumin Revenue by Country (2020-2025) &nbsp;7.2 Europe Pharmaceutical Excipient Albumin Sales by Type (2020-2025) &nbsp;7.3 Europe Pharmaceutical Excipient Albumin Sales by Application (2020-2025) &nbsp;7.4 Germany &nbsp;7.5 France &nbsp;7.6 UK &nbsp;7.7 Italy &nbsp;7.8 Russia 8 Middle East & Africa &nbsp;8.1 Middle East & Africa Pharmaceutical Excipient Albumin by Country &nbsp;8.1.1 Middle East & Africa Pharmaceutical Excipient Albumin Sales by Country (2020-2025) &nbsp;8.1.2 Middle East & Africa Pharmaceutical Excipient Albumin Revenue by Country (2020-2025) &nbsp;8.2 Middle East & Africa Pharmaceutical Excipient Albumin Sales by Type (2020-2025) &nbsp;8.3 Middle East & Africa Pharmaceutical Excipient Albumin Sales by Application (2020-2025) &nbsp;8.4 Egypt &nbsp;8.5 South Africa &nbsp;8.6 Israel &nbsp;8.7 Turkey &nbsp;8.8 GCC Countries 9 Market Drivers, Challenges and Trends &nbsp;9.1 Market Drivers & Growth Opportunities &nbsp;9.2 Market Challenges & Risks &nbsp;9.3 Industry Trends 10 Manufacturing Cost Structure Analysis &nbsp;10.1 Raw Material and Suppliers &nbsp;10.2 Manufacturing Cost Structure Analysis of Pharmaceutical Excipient Albumin &nbsp;10.3 Manufacturing Process Analysis of Pharmaceutical Excipient Albumin &nbsp;10.4 Industry Chain Structure of Pharmaceutical Excipient Albumin 11 Marketing, Distributors and Customer &nbsp;11.1 Sales Channel &nbsp;11.1.1 Direct Channels &nbsp;11.1.2 Indirect Channels &nbsp;11.2 Pharmaceutical Excipient Albumin Distributors &nbsp;11.3 Pharmaceutical Excipient Albumin Customer 12 World Forecast Review for Pharmaceutical Excipient Albumin by Geographic Region &nbsp;12.1 Global Pharmaceutical Excipient Albumin Market Size Forecast by Region &nbsp;12.1.1 Global Pharmaceutical Excipient Albumin Forecast by Region (2026-2031) &nbsp;12.1.2 Global Pharmaceutical Excipient Albumin Annual Revenue Forecast by Region (2026-2031) &nbsp;12.2 Americas Forecast by Country (2026-2031) &nbsp;12.3 APAC Forecast by Region (2026-2031) &nbsp;12.4 Europe Forecast by Country (2026-2031) &nbsp;12.5 Middle East & Africa Forecast by Country (2026-2031) &nbsp;12.6 Global Pharmaceutical Excipient Albumin Forecast by Type (2026-2031) &nbsp;12.7 Global Pharmaceutical Excipient Albumin Forecast by Application (2026-2031) 13 Key Players Analysis &nbsp;13.1 CSL &nbsp;13.1.1 CSL Company Information &nbsp;13.1.2 CSL Pharmaceutical Excipient Albumin Product Portfolios and Specifications &nbsp;13.1.3 CSL Pharmaceutical Excipient Albumin Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.1.4 CSL Main Business Overview &nbsp;13.1.5 CSL Latest Developments &nbsp;13.2 Grifols &nbsp;13.2.1 Grifols Company Information &nbsp;13.2.2 Grifols Pharmaceutical Excipient Albumin Product Portfolios and Specifications &nbsp;13.2.3 Grifols Pharmaceutical Excipient Albumin Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.2.4 Grifols Main Business Overview &nbsp;13.2.5 Grifols Latest Developments &nbsp;13.3 Takeda &nbsp;13.3.1 Takeda Company Information &nbsp;13.3.2 Takeda Pharmaceutical Excipient Albumin Product Portfolios and Specifications &nbsp;13.3.3 Takeda Pharmaceutical Excipient Albumin Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.3.4 Takeda Main Business Overview &nbsp;13.3.5 Takeda Latest Developments &nbsp;13.4 Octapharma &nbsp;13.4.1 Octapharma Company Information &nbsp;13.4.2 Octapharma Pharmaceutical Excipient Albumin Product Portfolios and Specifications &nbsp;13.4.3 Octapharma Pharmaceutical Excipient Albumin Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.4.4 Octapharma Main Business Overview &nbsp;13.4.5 Octapharma Latest Developments &nbsp;13.5 Hualan Bio &nbsp;13.5.1 Hualan Bio Company Information &nbsp;13.5.2 Hualan Bio Pharmaceutical Excipient Albumin Product Portfolios and Specifications &nbsp;13.5.3 Hualan Bio Pharmaceutical Excipient Albumin Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.5.4 Hualan Bio Main Business Overview &nbsp;13.5.5 Hualan Bio Latest Developments &nbsp;13.6 CBPO &nbsp;13.6.1 CBPO Company Information &nbsp;13.6.2 CBPO Pharmaceutical Excipient Albumin Product Portfolios and Specifications &nbsp;13.6.3 CBPO Pharmaceutical Excipient Albumin Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.6.4 CBPO Main Business Overview &nbsp;13.6.5 CBPO Latest Developments &nbsp;13.7 Shanghai RAAS &nbsp;13.7.1 Shanghai RAAS Company Information &nbsp;13.7.2 Shanghai RAAS Pharmaceutical Excipient Albumin Product Portfolios and Specifications &nbsp;13.7.3 Shanghai RAAS Pharmaceutical Excipient Albumin Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.7.4 Shanghai RAAS Main Business Overview &nbsp;13.7.5 Shanghai RAAS Latest Developments &nbsp;13.8 Kedrion &nbsp;13.8.1 Kedrion Company Information &nbsp;13.8.2 Kedrion Pharmaceutical Excipient Albumin Product Portfolios and Specifications &nbsp;13.8.3 Kedrion Pharmaceutical Excipient Albumin Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.8.4 Kedrion Main Business Overview &nbsp;13.8.5 Kedrion Latest Developments &nbsp;13.9 LFB Group &nbsp;13.9.1 LFB Group Company Information &nbsp;13.9.2 LFB Group Pharmaceutical Excipient Albumin Product Portfolios and Specifications &nbsp;13.9.3 LFB Group Pharmaceutical Excipient Albumin Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.9.4 LFB Group Main Business Overview &nbsp;13.9.5 LFB Group Latest Developments &nbsp;13.10 Albumedix &nbsp;13.10.1 Albumedix Company Information &nbsp;13.10.2 Albumedix Pharmaceutical Excipient Albumin Product Portfolios and Specifications &nbsp;13.10.3 Albumedix Pharmaceutical Excipient Albumin Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.10.4 Albumedix Main Business Overview &nbsp;13.10.5 Albumedix Latest Developments &nbsp;13.11 Biotest &nbsp;13.11.1 Biotest Company Information &nbsp;13.11.2 Biotest Pharmaceutical Excipient Albumin Product Portfolios and Specifications &nbsp;13.11.3 Biotest Pharmaceutical Excipient Albumin Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.11.4 Biotest Main Business Overview &nbsp;13.11.5 Biotest Latest Developments &nbsp;13.12 Merck &nbsp;13.12.1 Merck Company Information &nbsp;13.12.2 Merck Pharmaceutical Excipient Albumin Product Portfolios and Specifications &nbsp;13.12.3 Merck Pharmaceutical Excipient Albumin Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.12.4 Merck Main Business Overview &nbsp;13.12.5 Merck Latest Developments &nbsp;13.13 Ventria (InVitria) &nbsp;13.13.1 Ventria (InVitria) Company Information &nbsp;13.13.2 Ventria (InVitria) Pharmaceutical Excipient Albumin Product Portfolios and Specifications &nbsp;13.13.3 Ventria (InVitria) Pharmaceutical Excipient Albumin Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.13.4 Ventria (InVitria) Main Business Overview &nbsp;13.13.5 Ventria (InVitria) Latest Developments &nbsp;13.14 HiMedia &nbsp;13.14.1 HiMedia Company Information &nbsp;13.14.2 HiMedia Pharmaceutical Excipient Albumin Product Portfolios and Specifications &nbsp;13.14.3 HiMedia Pharmaceutical Excipient Albumin Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.14.4 HiMedia Main Business Overview &nbsp;13.14.5 HiMedia Latest Developments 14 Research Findings and Conclusion

Report	Global Pharmaceutical Excipient Albumin Market Growth 2025-2031
Selected License	Single ID:LPI35327

Buyer Information

Order Summary